Pharmatica

In this special Scientific Council Spotlight episode of The Discovery Loop podcast, host Shubhangi Dua, Journalist, Podcast Producer and Podcast Host at Pharmatica.io, sits down with Deepankar Nayak, the CEO of Deep Longevity. Nayak also serves on Pharmatica’s Scientific Council.

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

“The pharma industry is beginning to look at biological age as a surrogate endpoint to improve clinical trials."

In the recent episode of The Clinical Compass podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, is joined by Dr Amber Hill, Founder and CEO of Research Grid. They talk about how pharmaceutical companies and their leaders should approach the use of AI in clinical trials.

In the recent episode of The Discovery Loop podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io, sat down with Diana Andrade, Founder & Managing Director at RD Privacy and Data Protection Officer (DPO) for Biopharma and Life Sciences. They talk about the current state of data protection regulations and how enterprises can innovate responsibly.

In the recent episode of The Chain Reaction podcast, Nour AlSaleh, Founder and CEO of Veragence Pharma Consultancy, sat down with host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io and EM360Tech. AlSaleh shares her expertise on maintaining data integrity in this new era of AI and changing policies.

Kate O’Reilly, President & Chair of the Healthcare Businesswomen’s Association (HBA) Dublin-Ireland Chapter & Healthcare Transformation Partner at Roche, discusses AI in pharma, patient engagement, and the future of healthcare innovation.

In the recent episode of the Digital Pulse podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, sat down with Lara Masad, an AI and Data Innovation independent consultant, to clarify the key distinctions in AI and machine learning models. Furthermore, Masad explains how pharmaceutical companies benefit from using AI models.

Trisha Pillay speaks with Judit Mora, CEO of Nuumad, on Digital Pulse discussing pharmacy innovation, market access barriers, and new models for faster patient access to healthcare.

Trisha Pillay speaks with Dineshree Naiker, co-founder of Umsebe Healthcare, on Chain Reaction discussing regulatory leadership, pharmaceutical supply chains, and improving patient access to medicines.

Exclusive Pharmatica Content

Explore expert-led podcasts, pharmaceutical intelligence, life sciences insights and research-driven analysis from leading industry voices. Pharmatica delivers trusted biotech news, drug development trends and commercial intelligence for professionals across the pharmaceutical sector.

Nicole Dale

FDA Oncology Trial Guidance Targets Eligibility Barriers

Pharmatica image showing new FDA oncology clinical trial guidance for clinical trial eligibility represented through connected patient assessment, clinical research data, and trial pathways.

FDA oncology clinical trial guidance targets restrictive eligibility criteria, covering performance status, washout periods, medications, and laboratory values.

Nicole Dale

EHR Patient Recruitment Gets A Reality Check

Pharmatica image representing EHR patient recruitment technology connecting electronic health records, clinical trial eligibility data, and patient-trial matching.

EHR patient recruitment could improve clinical trial matching, but workflow integration, data quality, interoperability, and AI validation remain key challenges.

Nicole Dale

FDA Generic Peptides Guidance Sets New Expectations

Pharmatica visual of the FDA generic peptides guidance showing peptide molecular structure and regulatory assessment of generic peptide medicines.

Revised FDA draft guidance for generic peptide products updates expectations for ANDAs, impurities, structure, immune response, and biological activity.

Nicole Dale

The Ethics of Decentralised Clinical Trials

Pharmatica image representing decentralised clinical trials using remote monitoring, digital health technology, and telehealth to connect clinical research participants with investigators.

Ethical obligations in decentralised clinical trials extend beyond consent and privacy. Sponsors must protect safety, scientific validity, equity, and oversight.

Nicole Dale

Making Flexibility Work with Adaptive Clinical Trials

Pharmatica image showing two clinical researchers in white laboratory coats reviewing trial data on a digital tablet in a modern pharmaceutical research environment. The background shows laboratory equipment and translucent scientific graphics, symbolising adaptive clinical trial design, evidence‑driven decision‑making, and digital data integration in clinical development.

Adaptive clinical trials can improve efficiency, reduce patient burden, and support faster development through structured, evidence-based flexibility.

Nicole Dale

AI in GMP Manufacturing: Are Regulators Ready for Digital Factories?

Pharmatica image representing AI in pharmaceutical GMP manufacturing using machine learning, predictive maintenance, digital quality management, continuous manufacturing, and smart pharmaceutical production.

Learn how AI in pharmaceutical GMP manufacturing is improving quality, data integrity, predictive maintenance, and regulatory compliance in modern drug production.

Nicole Dale

Growing Patient and Public Involvement in Clinical Trials

Pharmatica image representing public and patient involvement in clinical trials. Shows a diverse group of clinical trial participants and researchers engaged in collaborative discussion around a bright white table in a modern research environment. A female doctor in a white lab coat leads the conversation, surrounded by older and younger participants of different ethnic backgrounds. Digital screens in the background display molecular structures and clinical data in blue tones, symbolising transparency.

Patient and public involvement in clinical trials improves study design. Learn why better reporting is essential for transparent, patient-centred research.

Nicole Dale

The Latest Evidence on Informed Consent in Clinical Trials

Pharmatica image representing informed consent in clinical trials with digital eConsent technology, participant engagement, clinical research ethics, transparent communication, and modern clinical trial management.

A recent systematic review reveals incredible detail about informed consent in clinical trials, participant understanding, and trial quality. Find out now.

Nicole Dale

Optimising Clinical Trial Data Collection for Better Decisions

Optimising clinical trial data collection Pharmatica image representing fit-for-purpose evidence generation.

Learn how optimised clinical trial data collection improves data quality, reduces protocol and patient burden, and supports smarter clinical development.

Nicole Dale

FAST-EU Pilot: Can Europe Finally Accelerate Multinational Clinical Trials?

Pharmatica image representing the FAST-EU Pilot supporting multinational clinical trials through coordinated European regulatory collaboration, accelerating clinical trial approvals under the EU Clinical Trials Regulation (CTR).

The FAST-EU Pilot aims to accelerate multinational clinical trials through faster coordinated assessments, supporting Europe’s 2030 clinical research ambitions.

Nicole Dale

One Pivotal Trial for FDA Approval? Success Depends on Trial Design

Pharmatica image of a modern pharmaceutical regulatory affairs workspace representing documentation, compliance, and submission processes essential for FDA drug approval. The scene shows three binders labeled “Regulatory Affairs,” “Submissions,” and “Compliance” on a clean office desk with documents and a pen in the foreground, while a blurred meeting of professionals is visible through a glass wall in the background. The composition conveys administrative precision and regulatory science underpinning.

One pivotal trial for FDA approval could accelerate drug development, reshape clinical trial strategy, and change the pharmaceutical regulatory landscape.

Nicole Dale

Europe’s Life Sciences Strategy. A New Era of Innovation?

Pharmatica picture of European pharmaceutical innovation showing biotechnology research, advanced manufacturing, artificial intelligence, and regulatory collaboration supporting the European Life Sciences Strategy.

The new European Life Sciences Strategy aims to accelerate pharmaceutical innovation through investment, regulatory reform, biotechnology, and AI capabilities.

Content type

Topic

Articles, expert interviews, and insights from life sciences leaders

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

FDA Oncology Trial Guidance Targets Eligibility Barriers

EHR Patient Recruitment Gets A Reality Check

FDA Generic Peptides Guidance Sets New Expectations

The Ethics of Decentralised Clinical Trials

Making Flexibility Work with Adaptive Clinical Trials

AI in GMP Manufacturing: Are Regulators Ready for Digital Factories?

Growing Patient and Public Involvement in Clinical Trials

The Latest Evidence on Informed Consent in Clinical Trials

Optimising Clinical Trial Data Collection for Better Decisions

FAST-EU Pilot: Can Europe Finally Accelerate Multinational Clinical Trials?

One Pivotal Trial for FDA Approval? Success Depends on Trial Design

Europe’s Life Sciences Strategy. A New Era of Innovation?